CTICases ← All cases

Pneumocystis jirovecii Pneumonia (PCP) in a Rheumatoid Arthritis Patient on Adalimumab

Imaging findings

CT in a rheumatoid arthritis patient on adalimumab (Humira) demonstrates diffuse bilateral ground-glass opacity in a crazy-paving pattern with small pleural effusions. Follow-up CT after treatment shows developing basilar fibrosis with traction bronchiectasis and a honeycombing-like pattern.

Key takeaways

TNF-alpha inhibitors such as adalimumab (Humira) are associated with opportunistic infections including Pneumocystis jirovecii pneumonia (PCP), which classically presents with diffuse bilateral ground-glass opacity in a crazy-paving pattern. Pleural effusions are atypical for PCP but may be attributable to the underlying rheumatoid arthritis. Post-PCP fibrosis may be indistinguishable from RA-ILD on subsequent imaging.

AI-assisted summary — may contain errors. Verify against the source video. Learn more

More from this webinar

See all cases from March 4, 2021 →

Related Infection cases

Browse all Infection cases →